Nordson (NDSN) PT Raised to $287 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Nordson Corporation Reports Third Quarter Fiscal 2024 Results and Updates Annual Guidance
August 21, 2024 4:30 PM EDTThird Quarter Highlights:
Sales were $662 million, an increase of 2% year-over-year and in-line with mid-point of guidance Earnings per diluted share were $2.04 Adjusted earnings per diluted share were $2.41, $0.08 above the mid-point of guidanceUpdated Full-Year Guidance:
Increasing full fiscal year 2024 revenue guidance to reflect the addition of Atrion acquisition Maintaining full fiscal year 2024 adjusted earnings per diluted share guidance, inclusive of the slightly dilutive fourth quarter Atrion acquisition impactWESTLAKE,... More
Nordson Corporation Completes Acquisition of Atrion Corporation
August 21, 2024 8:35 AM EDTWESTLAKE, Ohio--(BUSINESS WIRE)-- Nordson Corporation (Nasdaq: NDSN) (the Company or Nordson) has completed the acquisition of Atrion Corporation (Atrion), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions. The completion of the transaction follows the Companys May 28, 2024 announcement that it had entered into an agreement to acquire the business. This acquisition will expand Nordsons medical... More
